Phthalates are used in a large variety of products, such as building materials, medical devices, and personal care products. Most previous studies on the toxicity of phthalates have focused on single phthalates, but it is also important to study the effects of phthalate mixtures because humans are exposed to phthalate mixtures. Thus, we tested the hypothesis that prenatal exposure to an environmentally relevant phthalate mixture adversely affects female reproduction in mice. To test this hypothesis, pregnant CD-1 dams were orally dosed with vehicle (tocopherol-stripped corn oil) or a phthalate mixture (20 and 200 μg/kg/day, 200 and 500 mg/kg/day) daily from gestational day 10 to birth. The mixture was based on the composition of phthalates detected in urine samples from pregnant women in Illinois. The mixture included 35% diethyl phthalate, 21% di(2-ethylhexyl) phthalate, 15% dibutyl phthalate, 15% diisononyl phthalate, 8% diisobutyl phthalate, and 5% benzylbutyl phthalate. Female mice born to the exposed dams were subjected to tissue collections and fertility tests at different ages. Our results indicate that prenatal exposure to the phthalate mixture significantly increased uterine weight and decreased anogenital distance on postnatal days 8 and 60, induced cystic ovaries at 13 months, disrupted estrous cyclicity, reduced fertility-related indices, and caused some breeding complications at 3, 6, and 9 months of age. Collectively, our data suggest that prenatal exposure to an environmentally relevant phthalate mixture disrupts aspects of female reproduction in mice.
Introduction
Phthalates are synthetic chemicals that are widely used in common consumer products, including various plastics, cosmetics, personal care products, polyvinyl chloride pipes, and vinyl flooring (Koniecki et al., 2011; Xu et al., 2010) . Because of the ubiquitous characteristics of phthalates, humans at all ages are constantly exposed to phthalates through ingestion, inhalation, and dermal contact. Of particular concern, phthalates and their metabolites are present in pregnant women and can affect the health of the mothers as well as their offspring. Metabolites of many phthalates such as di(2-ethylhexyl) phthalate (DEHP), diethyl phthalate (DEP), dimethyl phthalate, dibutyl phthalate (DBP), benzyl butyl phthalate (BBzP), and diisobutyl phthalate (DiBP) have been frequently detected in urine samples from pregnant women (Meeker et al., 2009; Adibi et al., 2003; Adibi et al., 2008) . Moreover, urinary levels of DEHP and its metabolite, mono-ethylhexyl phthalate (MEHP), have been detected in maternal plasma and urine samples, and have been associated with decreased gestational age (Latini et al., 2003a; Weinberger et al., 2014) . Phthalate metabolites are also commonly found in fetal samples such as amniotic fluid and cord blood samples (Latini et al., 2003b; Jensen et al., 2015; Huang et al., 2014) . Collectively, these studies suggest that humans are constantly exposed to phthalates and that this exposure starts as early as fetal life.
Fetal life is considered to be one of the most sensitive periods to toxicants because of the critical developmental events that occur during this time period. Prenatal phthalate exposure has been shown to induce "phthalate syndrome" in male rodents (Foster, 2006; Gray et al., 2000) . This "phthalate syndrome" is characterized by malformations in the male reproductive organs, retention of nipples, and reduced anogenital distance (AGD) (Foster, 2006; Gray et al., 2000) . Moreover, gestational exposures to different phthalates have been shown to reduce fertility in male rodents by decreasing steroidogenic capacity, sperm quality and quantity, and sexual behaviors (Giribabu et al., 2014; Saffarini et al., 2012; Andrade et al., 2006; Dalsenter et al., 2006) . However, the effects of prenatal phthalate exposure on female reproduction in the offspring are less extensively studied. Published studies have shown that gestational exposure to DEHP affects folliculogenesis (Niermann et al., 2015) , reduces oocyte quality (Pocar et al., 2012) , decreases steroidogenic capacity (Pocar et al., 2012; Moyer and Hixon, 2012) , delays puberty (Moyer and Hixon, 2012) , and decreases fertility (Niermann et al., 2015; Pocar et al., 2012) . Toxicology and Applied Pharmacology 318 (2017) [49] [50] [51] [52] [53] [54] [55] [56] [57] Although studies on prenatal exposure to a single phthalate provide important information on phthalate toxicity, it is important to study mixtures of phthalates because humans are exposed to mixtures. Prenatal exposure to a mixture of DBP, DEHP, and bisphenol A reduced ovarian follicular reserve and induced polycystic ovaries in female offspring (Manikkam et al., 2013) . Prenatal exposure to a phthalate mixture (BBzP, DBP, DEHP, DiBP, and dipentyl phthalate) induced uterine malformations in female offspring (Hannas et al., 2013) . Prenatal exposure to a mixture of phthalates, pesticides, UV-filters, bisphenol A, butylparaben, and paracetamol significantly impaired female reproductive function in the offspring by reducing follicle numbers, disrupting estrous cycles, and decreasing ovarian weights (Johansson et al., 2016) . Only one of these previous studies, however, used a mixture that was based on human exposure, but the lowest dose used in that study was 100 times greater than the estimates of human exposure (Johansson et al., 2016) . Thus, there is a need for studies conducted using environmentally relevant phthalate mixtures at doses relevant to human exposure levels. Therefore, in our study, we developed a phthalate mixture based on estimates of phthalate exposure in pregnant women and we used this phthalate mixture at environmentally relevant doses to test the hypothesis that prenatal exposure to a phthalate mixture adversely affects reproductive outcomes in the F1 female offspring.
Materials and methods

Chemicals
DEP, DEHP, DBP, DiBP, diisononyl phthalate (DiNP), and BBzP (N98% purity) were purchased from Sigma-Aldrich (St. Louis, MO). A pure phthalate mixture was made by calculating and combining the appropriate amount of each phthalate according to the following percentages: 21% DEHP, 35% DEP, 15% DBP, 8% DiBP, 5% BBzP, and 15% DiNP. The percentages were derived from levels of phthalate metabolites measured in urine samples from pregnant women in Illinois (unpublished data from the iKids study). Then, the phthalate mixture was mixed thoroughly before dilution in tocopherol-stripped corn oil (vehicle control).
The doses used for this study were 20 μg/kg/day, 200 μg/kg/day, 200 mg/kg/day, and 500 mg/kg/day. This is the first time this phthalate mixture has been tested in vivo. Thus, doses of phthalate mixture were chosen to cover a wide environmentally relevant range and to include some of the doses of individual phthalates that have been shown to adversely affect reproductive health during prenatal exposure (Niermann et al., 2015; Pocar et al., 2012; Moyer and Hixon, 2012; Meltzer et al., 2015) . The estimated general population daily exposure level of DEHP is 3-30 μg/kg/day (Doull et al., 1999) . According to these estimates, the two lower doses used in our study mimic daily human exposure because they contain approximately 4 and 40 μg/kg/day of DEHP, respectively. We also included two high doses of mixture (200 and 500 mg/kg/day, which contain approximately 40 and 100 mg/kg/day of DEHP, respectively) to test the effects of this mixture at a level higher than human expose range and to compare our results with available information from single phthalate studies that used doses close to this level. Previous studies have shown that gestational exposure to DEHP decreased the thickness of thecal cell layers at 50 and 300 mg/kg/day (Meltzer et al., 2015) , disrupted steroidogenic enzyme gene expression and increased estradiol levels at 100 mg/kg/day (Moyer and Hixon, 2012) , increased preantral follicle numbers at 200 μg/kg/day and 500 mg/kg/day (Niermann et al., 2015) , increased ovarian weights at 0.05 and 5 mg/kg/day (Pocar et al., 2012) , and induced breeding complications at 200 μg/kg/day and 750 mg/kg/day (Niermann et al., 2015) .
Animals
Adult cycling female and adult male CD-1 mice were purchased from Jackson Laboratory (Bar Harbor, ME) and allowed to acclimate to the facility for at least two weeks before use. The mice were housed at the University of Illinois at Urbana-Champaign, Veterinary Medicine Animal Facility in polysulfone cages. Food (Harlan Teklad 8604) and water (reverse osmosis filtered) were provided for ad libitum consumption. Temperature was maintained at 22 ± 1°C, and animals were subjected to 12-h light-dark cycles. The Institutional Animal Care and Use Committee (IACUC) at the University of Illinois at Urbana-Champaign approved all procedures involving animal care, euthanasia, and tissue collection.
Study design
At two months of age, 60 females were mated with untreated proven breeder male mice. Successful mating was confirmed by the presence of vaginal sperm plug. Gestational day (GD) 1 was set as the day of the presence of vaginal sperm plug. Once the vaginal sperm plug was observed, female mice were separated and singly housed. These dams were considered to be the F0 generation, and their body weights were monitored every three days to confirm pregnancy. On GD 10, F0 dams were assigned to five different treatment groups (12 F0 dams/treatment group) and then were dosed once a day until they give birth. F0 dams were orally dosed by pipetting tocopherol-stripped corn oil (vehicle control) or different doses of phthalate mixture (20 μg/kg/day, 200 μg/kg/day, 200 mg/kg/day, and 500 mg/kg/day) into the mouth from GD 10 to birth.
The route of exposure was selected to mimic the major route of exposure in humans (Latini, 2005) . The exposure window was chosen because it is a critical period for ovarian development in the mouse. All doses were given in 28-44 μl based on their body weights. Dams were allowed to give birth naturally and the number of total and live pups, body weights of live pups, and sex ratio of the F1 pups were recorded on postnatal day (PND) 0.
Tissue collection, body weights, and organ weights
On PNDs 1, 4, 8, and 21, at least one female F1 pup per litter (n = 10-12 dams/treatment group) was randomly chosen for tissue collections. On PND 60 and 13 months of age, the remaining F1 female pups were euthanized and their tissues were collected during diestrus. At each time point, sera, ovaries, uteri, and livers were collected, organ weights and body weights were recorded, and anogenital distances (AGD) were measured. Organ weights were recorded as whole organ weights in grams, AGD was recorded in millimeters (mm), and ovaries from the same pup were measured together and recorded as one weight for PND 1-60. At 13 months of age, ovarian weights were based on one healthy ovary per mouse. The presence of cystic ovaries was recorded. We normalized AGD to cubic root of body weight to account for body size effects (Gallavan et al., 1999) . Sera were stored for measurement of hormone levels in future studies. Ovaries, uteri, and livers were snap-frozen or fixed for molecular or histological analyses in future studies.
Onset of puberty
After weaning, one F1 female per litter (n = 11-12 litters/treatment group) was kept for analyses of onset of puberty, estrous cyclicity, and fertility. Vaginal opening was used as a sign of onset of puberty and was monitored every morning after weaning. Body weights were recorded on the day of weaning and on the day of vaginal opening. After vaginal opening, estrous cyclicity was monitored every morning by examining vaginal smears daily for 30 consecutive days.
Fertility tests
One F1 female per litter (n = 7-12 litters/treatment group) was subjected to fertility tests at 3, 6, and 9 months of age. For each fertility test, estrous cyclicity was monitored every morning for 14 consecutive days prior to mating. Then, female mice were housed with untreated proven breeder male mice for maximum of 2 weeks to evaluate fertility of F1 females. Once a vaginal sperm plug was present, female mice were singly housed. Body weights were recorded twice a week starting from the first day of estrous cyclicity examination until the birth of pups. Maintenance or loss of pregnancy were monitored by body weight gain. For every female, the presence of a vaginal sperm plug, days to pregnancy, the ability to become and maintain pregnancy, and pregnancy lengths were recorded. The ability to deliver live pups, size of the litter, average live pup birth weight, and pup sex ratios were also recorded to evaluate the birth outcomes.
To examine fertility, we used several equations to calculate mating index, pregnancy rate, fertility index, and gestation index as previously described (Ziv-Gal et al., 2015) and as follows:
Pregnancy rate ¼ number of pregnant females=number of breeding pairs Â 100
Mating index ¼ number of females with vaginal sperm plugs=number of breeding pairs Â 100
Fertility index ¼ number of pregnant females=number of females with vaginal sperm plugs Â 100
Gestational index ¼ number of females who delivered=number of pregnant females Â 100
Statistical analyses
Data analyses were conducted using SPSS statistical software (SPSS Inc., Chicago, IL). One-way analysis of variance (ANOVA) was used to conduct multiple comparisons between normally distributed experimental groups, then followed by Dunnett post-hoc comparisons if equal variances were assumed, or Games-Howell post-hoc comparisons if equal variances were not assumed. Kruskal-Wallis H tests were used for comparison between groups if data were not normally distributed, followed by Mann-Whitney U two-independent sample tests. Statistical significance was assigned at p b 0.05. 
Results
Effect of phthalate mixture exposure on F0 fertility outcomes
The phthalate mixture did not affect the number of F0 females that gave birth to live litters (n = 10-12 dams/treatment group, p N 0.05, data not shown). The phthalate mixture also did not cause any effects on F0 body weight, ovary weight, uterine weight, liver weight, or relative organ weight compared to vehicle control (n = 11-12 dams/treatment group, p N 0.05, data not shown). Further, the phthalate mixture did not affect the number of total pups, number of live pups, average live pup body weights, and sex ratio of the F1 generation compared to the control groups (n = 10-12 dams/treatment group, p N 0.05, data not shown).
Effect of prenatal phthalate mixture exposure on F1 female pup tissues
Prenatal exposure to phthalate mixture did not affect the body and liver weights of F1 females compared to controls on PND 1 and 4 (Table 1, n = 10-12 dams/treatment). Prenatal exposure to phthalate mixture at 500 mg/kg/day significantly decreased AGD in F1 females compared to controls on PND 8 (Table 1 , n = 8-12 dams/treatment, p b 0.05). Moreover, prenatal exposure to phthalate mixture (20 μg/kg/day) increased uterine weight in the F1 females compared to controls on PND 8 (Table 1 , n = 8-12 dams/treatment, p b 0.05). Prenatal exposure to phthalate mixture did not affect body weight, liver weight, ovary weight, uteri weight, or AGD in F1 females compared to controls on PND 21 or at 13 months of age (Table 1 , n = 6-11 dams/ treatment). However, prenatal exposure to phthalate mixture at 20 and 200 μg/kg/day significantly decreased AGD in F1 females and it (500 mg/kg/day) increased uterine weight in F1 females compared to controls on PND 60 (Table 1 , n = 5-9 dams/treatment, p b 0.05).
Interestingly, prenatal exposure to the phthalate mixture caused cystic ovaries in F1 females at 13 months of age (Fig. 1) . In controls, none of the F1 females had cystic ovaries, but females in all phthalate treated groups had cystic ovaries with enlarged fluid or blood filled cysts (Table 2) .
Effect of prenatal phthalate mixture exposure on F1 pubertal outcomes
Prenatal exposure to phthalate mixture at 20 μg/kg/day decreased F1 body weights at vaginal opening compared to controls ( Fig. 2A , n = 10-12, p b 0.05), but it did not significantly affect the age at vaginal opening 
Table 2
The effects of prenatal exposure to phthalate mixture on the occurrence of cystic ovaries in F1 females.
Treatment
Total number of females in F1 females compared to controls (Fig. 2B, n = 10-12) . However, prenatal exposure to phthalate mixture at 200 μg/kg/day borderline significantly reduced the days between vaginal opening and the first estrus in F1 females compared to controls (Fig. 2C , n = 10-12, p = 0.061). Prenatal phthalate mixture exposure did not affect the time mice spent in proestrus in the 30 days after vaginal opening in F1 females compared to control (Fig. 3A, n = 10-12) . However, at all doses, prenatal phthalate mixture exposure increased the time F1 mice spent in estrus and decreased the time they spent in metestrus and diestrus combined in the 30 days after vaginal opening compared to control (Fig. 3A , n = 10-12, *p b 0.05,^p = 0.057 for estrus,^p = 0.063 for metestrus/diestrus).
3.4. Effect of prenatal phthalate mixture exposure on F1 body weights and cyclicity over time Prenatal phthalate mixture exposure did not affect F1 body weights at 3, 6, 9, and 13 months of age compared to controls (Table 3 , n = 7-12). At 3 months, prenatal exposure to phthalate mixture did not affect the time F1 mice spent in proestrus (Fig. 3B , n = 11-12), but it increased the time spent in estrus and decreased the time spent in metestrus/diestrus combined at all doses in F1 females compared to controls (Fig. 3B , n = 11-12,^p = 0.077 for estrus,^p = 0.059 for metestrus/diestrus). At 6 months, prenatal exposure to phthalate mixture at 20 μg/kg/day, 200 mg/kg/day, and 500 mg/kg/day significantly decreased the time F1 mice spent in proestrus, but at 500 mg/kg/day, it increased the time F1 mice spent in estrus compared to control (Fig. 3C , n = 10-12, p b 0.05). At 13 months, prenatal exposure to phthalate mixture did not affect F1 estrous cyclicity compared to control (Fig. 3D , n = 7-9).
3.5. Effect of prenatal phthalate mixture exposure on F1 fertility over time At 3 months, prenatal exposure to phthalate mixture at 200 mg/kg/ day significantly increased the number of days the F1 mice needed to become pregnant compared to controls (Fig. 4A , n = 11-12, p b 0.05), but it did not affect pregnancy length in F1 females compared to controls (n = 10-12, data not shown). At this time point, prenatal exposure to phthalate mixture also caused some breeding complications in the F1 females. Specifically, one F1 female in the control group lost her pregnancy. One F1 female in the 200 mg/kg/day group successfully mated, but did not become pregnant and one F1 female in the same treatment group lost her pregnancy. One F1 female in the 500 mg/kg/day group successfully mated, but did not become pregnant. This resulted in a reduced pregnancy rate and fertility index in the 200 and 500 mg/kg/day treatment groups compared to control (Table 4 , n = 10-12). As far as birth outcomes, the phthalate mixture did not affect live and total F2 pup numbers, average F2 pup birth weight, or percent F2 females compared to control (n = 9-11, data not shown).
At 6 months of age, prenatal exposure to the phthalate mixture did not affect the time F1 mice needed to become pregnant (Fig. 4B , n = 10-12). Phthalate mixture exposure also did not affect pregnancy length compared to controls (n = 10-12, data not shown). At this time point, prenatal exposure to phthalate mixture caused some breeding complications in F1 females. Specifically, one F1 female in the 20 μg/ kg/day group successfully mated, but did not become pregnant, and two F1 females in the 200 μg/kg/day group successfully mated, but did not become pregnant and one F1 female in this group lost her pregnancy. Further, two F1 females in the 200 mg/kg/day group successfully mated, but did not become pregnant and two F1 females in the same group lost their pregnancy. In addition, one F1 female in the 500 mg/ Fig. 3 . The effects of prenatal exposure to phthalate mixture on estrous cyclicity after vaginal opening, and at 3, 6, and 13 months of age in F1 females. Estrous cyclicity after vaginal opening in F1 females is shown in panel A. Estrous cyclicity at 3 months in F1 females is shown in panel B. Estrous cyclicity at 6 months in F1 females is shown in panel C. Estrous cyclicity at 13 months in F1 females is shown in panel D. Graphs represent means ± SEM from 7 to 12 dams per treatment group. Asterisks (*) indicate significant differences from the control (p b 0.05).^indicates borderline significance compared to control (panel A, p = 0.057 for estrus, p = 0.063 for metestrus/diestrus. Panel B, p = 0.077 for estrus, p = 0.059 for metestrus/diestrus). kg/day group successfully mated, but did not become pregnant and one F1 female in the same group experienced dystocia. In contrast, only one F1 female in the control group lost her pregnancy. Taken together, this resulted in a reduced pregnancy rate and fertility index in the phthalate mixture treated groups compared to controls (Table 4 , n = 10-12). As far as birth outcomes, the phthalate mixture at 200 μg/kg/day significantly decreased the number of live and total F2 pups born to the F1 females compared to control animals (Fig. 5A , n = 7-10, p b 0.05), but it did not affect average F2 pup birth weight or percent of F2 females compared to control ( Fig. 5B and C, n = 7-10).
At 9 months of age, the phthalate mixture did not affect the time F1 mice needed to become pregnant (Fig. 4C , n = 7-11). Phthalate mixture exposure also did not affect pregnancy length compared to controls (n = 7-11, data not shown). However, prenatal exposure to phthalate mixture caused breeding complications in F1 females. Specifically, one F1 female in the 20 μg/kg/day lost her pregnancy and two F1 females in the same group experienced dystocia. Further, three F1 females in the 200 μg/kg/day group lost their pregnancies. In addition, one F1 female in the 200 mg/kg/day group lost her pregnancy and one female in the same group never mated. One F1 female in the 500 mg/kg/day group lost her pregnancy and two F1 females in the same group experienced dystocia. In contrast, only one F1 control female did not become pregnant after a successful mating. Taken together, this resulted in a reduced mating index and gestational index in the phthalate mixture treated groups compared to controls (Table 4 , n = 7-11). As far as birth outcomes, the phthalate mixture did not affect F2 live and total pup numbers, average F2 pup birth weight, or percent F2 females compared to control (n = 7-11, data not shown).
Discussion
Previous animal studies have shown that exposure to phthalates during different exposure windows causes various reproductive and developmental defects in both male and female animals (reviewed in (Kay et al., 2014; Kay et al., 2013) ). Most of these previous studies were conducted using single phthalates and the doses used in these studies were usually much higher than human exposure levels (reviewed in (Kay et al., 2014; Kay et al., 2013) ). Given that humans and animals are exposed to a mixture of different phthalates on daily basis, it is important to study the effects of phthalate mixtures on reproductive outcomes. Thus, this study was designed to determine if exposure to an environmentally relevant phthalate mixture at doses comparable to human exposure levels during a critical ovarian developmental window has adverse effects on female reproduction throughout reproductive life. To our knowledge, this is the first study to provide information on the effects of an environmentally relevant phthalate mixture on female reproduction. In our study, we found that prenatal exposure to the phthalate mixture decreased AGD, increased uterine weight, disrupted estrous cyclicity, reduced fertility-related indices, caused some breeding complications, and induced cystic ovaries in the F1 female mice (Table 5) .
Our data indicate that phthalate mixture exposure did not cause gestational complications in F0 females. F0 female mice in all treatment groups successfully gave birth to live litters, and the birth outcomes in the phthalate mixture exposed animals were comparable to controls. This indicates that phthalate mixture exposure did not cause fetal toxicity or overt maternal toxicity, which could lead to reduced litter size and birth defects in the pups. These findings differ from previous studies on Fig. 4 . The effects of prenatal exposure to phthalate mixture on time to pregnancy at 3, 6, and 9 months of age in F1 females. The effects of prenatal exposure to phthalate mixture on time to pregnancy at 3 months of age in F1 females are shown in panel A. The effects of prenatal exposure to phthalate mixture on time to pregnancy at 6 months of age in F1 females are shown in panel B. The effects of prenatal exposure to phthalate mixture on time to pregnancy at 9 months of age in F1 females are shown in panel C. Graphs represent means ± SEM from 7 to 12 dams per treatment group. Asterisk (*) indicates significant differences from the control (p b 0.05).
Table 3
The effects of prenatal exposure to phthalate mixture on body weight in F1 females.
Treatments
Age of pups (F1) 3 months (g) 6 months (g) 9 months (g) 13 months (g) gestational exposure to BBzP, DBP, and DEHP, which showed that these individual phthalates induced pregnancy loss and reduced litter size in rats and mice (Pocar et al., 2012; Ema et al., 2000; Ema et al., 1998; Gray et al., 2006) . The reasons for differences in our mixture study versus previous studies using single phthalates are probably due to the lower doses used in our study compared to previous studies. The dose range we included in our study was from 20 μg/kg/day to 500 mg/kg/ day, however, the lowest doses that caused adverse effects used in the aforementioned studies was 500 mg/kg/day (doses used in previous studies ranged from 0.05 to 1500 mg/kg/day for a single phthalate) (Pocar et al., 2012; Ema et al., 2000; Ema et al., 1998; Gray et al., 2006) . In addition, differences in our results from previous studies could be due to the differences in exposure window. In our study, we exposed pregnant dams during the second half of gestation, however, in the studies in which pregnancy loss and reduced litter size were observed, the exposure windows were either only during the first half of the gestation (Ema et al., 2000; Ema et al., 1998) or throughout the whole gestation period (Pocar et al., 2012; Gray et al., 2006) .
Our data showed that prenatal exposure to the phthalate mixture increased uterine weight on PND 8 and 60. Uterine weight is affected by sex steroid hormone levels. Thus, it is possible that in the phthalate mixture exposed F1 females, steroidogenesis was disrupted by the mixture exposure. On PND 8, the pups still depend on the dams and are sexually immature. The hypothalamus-pituitary-ovary axis is not fully functioning on PND 8, and as a result, the hormone levels in F1 females are heavily influenced by the hormone levels in the dams. Studies have shown that exposure to single phthalates affects steroidogenesis in female mice (Pocar et al., 2012; Svechnikova et al., 2007; Ma et al., 2006) . Thus, it is possible that the phthalate mixture exposure adversely affected sex steroid hormone levels in the dams and in turn induced differences in uterine weights in the PND 8 pups. Moreover, our data showed that prenatal exposure to phthalate mixture also increased uterine weight on PND 60 in F1 females. At this age, mice have a functional hypothalamus-pituitary-ovary axis and the uteri are responsive to hormone actions. Thus, it is possible that at this age, the phthalate mixture induced disruption in steroid hormone levels in the exposed F1 females and this led to an increase in uterine weight in the F1 pups. Increased uterine weight has been observed in F1 females prenatally exposed to DEHP and altered steroidogenesis has been observed in follicles exposed to DEHP (Niermann et al., 2015; Hannon et al., 2015) . Thus, future studies should examine the effects of the phthalate mixture on sex steroid hormone levels and determine if the phthalate mixture induced increase in uterine weight is due to altered sex steroid hormone levels.
Prenatal exposure to the phthalate mixture reduced AGD on PNDs 8 and 60. Phthalates have been shown to reduce AGD in male offspring after prenatal exposure in both singular and mixture forms (Foster, 2006; Howdeshell et al., 2015; Howdeshell et al., 2007) . Similar to results obtained from prenatal phthalate exposure studies in males, our results show that the phthalate mixture reduces AGD in F1 females. This outcome is likely due to the mixture reducing maternal androgen levels in the F1 females because AGD is determined by maternal androgen levels. Future studies are needed to measure sex steroid hormone levels of pregnant F0 dams to further confirm our hypotheses. In phthalate mixture exposed F1 females, we frequently observed enlarged ovaries with fluid or blood filled cysts, whereas enlarged cystic ovaries were not observed in any control animals. The presence of ovarian cysts is often a sign of reproductive aging (Creasy and Mann, 2012) . Similar phenotypes have been observed in aged mice, transgenic mice, and ovarian diseases mouse models (Fleming et al., 2007; Ferguson et al., 2016; Bristol-Gould et al., 2005) . Specifically, one study showed that CD-1 mice develop ovarian inclusion cysts starting at 6 months of age, but enlarged ovarian cysts were observed in a 9 month old animal (Fleming et al., 2007) . In a transgenic mouse model with conditionally activated Notch1, enlarged ovarian cysts developed in 8 month old animals (Ferguson et al., 2016) . In a transgenic mouse model for the study of ovarian endosalpingiosis, enlarged ovarian cysts, similar to the cysts observed in our study, were observed in animals at 8 months of age or older (Bristol-Gould et al., 2005) . Because we only observed the ovarian cysts in phthalate mixture treated F1 females, it is likely that phthalate mixture advanced reproductive senescence, or the mixture triggered other pathological changes indicated by the transgenic or induced ovarian diseases mouse models. Based on origin, ovarian cysts can be divided into follicular cysts, rete ovarii cysts, paraovarian cysts, luteal cysts, luteinized follicle cysts, and unspecified cysts (Dixon et al., 2014) . Based on appearance, the cysts that we observed in the phthalate mixture treated F1 females are likely to be epithelial cysts or rete ovarii cysts, but it is difficult to distinguish epithelial ovarian cysts and rete ovarii cysts based on appearance alone (Dixon et al., 2014) . Thus, further histological evaluations are needed to determine the origin of the cysts in the phthalate mixture treated F1 mice.
In our study, prenatal exposure to phthalate mixture did not affect age at vaginal opening and age of first estrus. This is similar to previous study results on prenatal exposure to DEHP, in which no effects of DEHP were observed on the age at vaginal opening, weight at vaginal opening, or age at first estrus at any doses (20 μg/kg/day to 750 mg/kg/day) (Niermann et al., 2015) . In contrast, prenatal exposure to BBzP or MEHP have been shown to delay puberty onset (Moyer and Hixon, 2012; Moral et al., 2011) ; however, the doses that were reported to delay puberty onset (≥500 mg/kg/day) were much higher than any of the individual phthalates used in the mixture in our study.
Our estrous cyclicity data indicate that prenatal exposure to the phthalate mixture significantly disrupted estrous cyclicity in F1 females. We observed that prenatal phthalate mixture exposure at all doses significantly prolonged the stage of estrus at peripuberty and at 3 months of age. This differs from previous studies which showed that prenatal exposure to DEHP did not affect estrous cyclicity at the peripubertal stage (Niermann et al., 2015) . However, our results are similar to a study that showed that adult exposure to DEHP increased the time mice spent in estrus compared to controls (Hannon et al., 2014) . Further, a prepubertal DEHP exposure study has shown that DEHP exposure affects ovarian steroidogenesis (Lai et al., 2016) , which could lead to disrupted estrous cyclicity. In addition, we speculate that the phthalate mixture could affect the establishment of hypothalamic-pituitary-ovarian axis, possibly by affecting hypothalamic kisspeptin levels to disrupt estrous cyclicity. This speculation is supported by both animal and epidemiology studies, which showed that phthalates exposure interferes with kisspeptin levels (Lai et al., 2016; Hu et al., 2013; Chen et al., 2013) . Disrupted estrous cyclicity often indicates disrupted ovarian function and sex steroid hormone levels and it may also indicate early reproductive senescence (Creasy and Mann, 2012) . Our results on estrous cyclicity are in accordance with our observation of cystic ovaries at 13 months of age in the phthalate mixture exposed females, in which the presence of the cysts may indicate disrupted ovarian function and ovarian aging.
Prenatal exposure to the phthalate mixture affected fertility-related indices in F1 females at 3, 6, and 9 months of age. At 3 months of age, our results showed that F1 females in the 200 mg/kg/day group took longer to become pregnant compared to control. This is likely due to the disruption of estrous cyclicity by the phthalate mixture at 3 months of age. Many phthalates have been shown to induce breeding complications and pregnancy loss (Niermann et al., 2015; Pocar et al., 2012; Ema et al., 2000; Ema et al., 1998; Gray et al., 2006; Schmidt et al., 2012) . In our study, phthalate mixture exposed F1 females experienced some breeding complications, including failure to mate, failure to become pregnant after successful mating, loss of pregnancy, and dystocia. Several of these complications became more apparent as the animals aged. Specifically, we observed more pregnancy loss and dystocia at 6 and 9 months of age than at 3 months of age, even at the lower doses. It is possible that prenatal exposure to phthalate mixture disrupted the development and functionality of the uterine tissues, and as a result, accelerated uterine aging. It could also due to the disrupted production of hormones that are required to maintain pregnancy. Further investigations on the uterine tissue and pregnancy related hormone levels are needed to elucidate the causes of pregnancy loss. It is difficult to distinguish early pregnancy loss and implantation failure based on the body weight alone. In our study, we defined pregnancy loss as N4 g of weight loss during gestation. As a result, the rate of pregnancy loss might be higher than what we reported.
In conclusion, our data indicate that prenatal exposure to an environmentally relevant phthalate mixture disrupts female reproduction in the F1 offspring in mice. Specifically, prenatal exposure to the phthalate mixture affects organ weights, induces pathological changes in ovaries, disrupts estrous cyclicity, reduces fertility-related indices, and causes some breeding complications in F1 female mice. To our knowledge, this is the first study that used a phthalate mixture mimicking human exposure and examined the effects on female reproduction. However, our study did not provide mechanistic evaluation of the phthalate mixture induced effects. Thus, future analyses are needed to determine the underlying mechanisms of action of this phthalate mixture. Additionally, many endocrine disrupting chemicals have been shown to have transgenerational effects (Ziv-Gal et al., 2015; Kay et √(9 months) Reduced pregnancy rate √(6 months) √(6 months) √(3, 6, and 9 months) √(3 and 6 months) Reduced fertility index √(6 months) √(6 months) √(3 and 6 months) √(3 and 6 months) Reduced gestational index √(9 months) √(6 and 9 months) √(3, 6, and 9 months) √(6 and 9 months) Disrupted estrous cyclicity √(3 and 6 months) √(after vaginal opening and at 3 months) √(after vaginal opening and at 6 months) √(after vaginal opening, and at 3 and 6 months) Increased time to pregnancy √(3 months) Decreased litter size √(6 months) al., 2014; Kay et al., 2013) ; thus, it is of great interest to determine if a mixture of phthalates could induce transgenerational effects on female reproduction.
